SOPHiA GENETICS SA (SOPH)
Fuera de horario:
SOPHiA GENETICS SA
La Pièce 12
Rolle 1180
Switzerland
41 21 694 10 60
https://www.sophiagenetics.com
Sector(es): Healthcare
Industria: Health Information Services
Empleados a tiempo completo: 430
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, CEO & Director | 1.08M | N/D | 1979 |
| Mr. Ross Jordan Muken B.Sc. | Executive VP, CFO & COO | N/D | N/D | 1981 |
| Mr. Abhimanyu Verma | Senior VP & CTO | N/D | N/D | N/D |
| Dr. Zhenyu Xu Ph.D. | Executive VP & Chief Scientific Officer | N/D | N/D | 1983 |
| Katherine Bailon | Vice President of Investor Relations | N/D | N/D | N/D |
| Mr. Daan van Well L.L.M., M.B.A. | Executive VP, Chief Legal & Compliance Officer | N/D | N/D | 1975 |
| Ms. Manuela Da Silva Valente B.A. | Executive VP & Chief People Officer | N/D | N/D | 1971 |
| Mr. Kevin Puylaert | VP & MD of EMEA | N/D | N/D | N/D |
| Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive VP, Chief Medical Officer & Chief Product Officer | N/D | N/D | 1982 |
| Mr. Peter Casasanto | Senior VP & Chief BioPharma Officer | N/D | N/D | N/D |
Descripción
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Gestión corporativa
La calificación ISS Governance QuickScore de SOPHiA GENETICS SA a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
